Derrick White’s value continues to go noticed by Celtics: ‘We’re lucky to have him’
Published Tue, 04 Mar 2025 08:18:28 GMT
Red Sox add two prospects to 40-man roster ahead of Rule 5 Draft
Published Tue, 04 Mar 2025 08:18:28 GMT
Greater Boston Housing Report Card is in and it’s not good
Published Tue, 04 Mar 2025 08:18:28 GMT
Benet’s Gabriel Sularski has 10 offers from Division I programs, which include Illinois. Next: His varsity debut.
Published Tue, 04 Mar 2025 08:18:28 GMT
Boston Mayor Wu pitches rent control as way to combat ‘housing crisis’
Published Tue, 04 Mar 2025 08:18:28 GMT
Teamsters President Sean O’Brien is challenged to a ‘cage match’ by Oklahoma Sen. Markwayne Mullin
Published Tue, 04 Mar 2025 08:18:28 GMT
2 women accused of helping Georgia inmate who escaped jail last month
Published Tue, 04 Mar 2025 08:18:28 GMT
Former CEO at center of fake Basquiats scandal countersues museum, claiming he is being scapegoated
Published Tue, 04 Mar 2025 08:18:28 GMT
Anchorage adds more shelter beds after unusually high amount of snow and record outdoor deaths
Published Tue, 04 Mar 2025 08:18:28 GMT
Man charged with abducting Michigan teen who was strangled dies while awaiting trial
Published Tue, 04 Mar 2025 08:18:28 GMT
Latest news
- White House to announce first-ever federal office of gun violence prevention, AP sources say
- A panel finds torture made a 9/11 defendant psychotic. A judge will rule whether he can stand trial
- As more patients email doctors, health systems start charging fees
- Two dead, dog injured, in suspected DUI crash on SR-76
- Suspect in ambush killing of LA deputy pleads not guilty due to insanity
- Quavo steps up advocacy against gun violence after his nephew Takeoff’s shooting death
- Blue Jays call up Cam Eden, option Ernie Clement to triple-A Buffalo
- Cross-country rallies against ‘gender ideology’ in schools meet with counter-protests
- Jeep maker Stellantis makes a new contract offer as auto workers prepare to expand their strike
- Revolving door redux: The DEA’s recently departed No. 2 returns to a Big Pharma consulting firm